Cord blood stem cell-generated KIR+NK cells effectively target leukemia cell lines.
Dizaji Asl K, Rafat A, Mazloumi Z, Valipour B, Movassaghpour A, Talebi M, Mahdavi M, Tayefi Nasrabadi H, Nozad Charoudeh H.
Dizaji Asl K, et al.
Hum Immunol. 2023 Feb;84(2):98-105. doi: 10.1016/j.humimm.2022.10.010. Epub 2022 Nov 14.
Hum Immunol. 2023.
PMID: 36396515
Because current treatments are insufficient and have a variety of side effects, researchers are looking for new and more effective therapeutic methods. Interestingly, ongoing efforts to find the best approach to optimize NK cell anti-leukemia potential shed light on the su …
Because current treatments are insufficient and have a variety of side effects, researchers are looking for new and more effective therapeut …